The Lyme disease diagnostic market is experiencing significant growth (CAGR 5.5%), driven by rising incidence, technological advancements, and increased awareness. This report analyzes market trends, key players (Bio-Rad, Abbott, Roche), and regional variations (North America, Europe) from 2019-2033. Explore detailed insights into serological tests, Western blot, and nucleic acid testing.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.